Mary K. McKenna

Engineered off-the-shelf therapeutic T cells resist host immune rejection

Feiyan Mo, Norihiro Watanabe, Mary K. McKenna et al. · Nature Biotechnology · 2020 · 143 citations · Full text

Life Sciences, Cell Biology, Immunology +14

Activated human N-ras oncogene enhances x-irradiation repair of mammalian cells in vitro less effectively at low dose rate

Thomas J. FitzGerald, Candace Daugherty, Kenneth R. Kase et al. · American Journal of Clinical Oncology · 1985 · 84 citations

Medicine, Cell Biology, Oncology +17

Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity

Mary K. McKenna, Alexander Englisch, Benjamin Brenner et al. · Molecular Therapy · 2021 · 76 citations · Full text

Pharmacy, Immunology, Oncology +17

Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer

Saisha Nalawade, Paul Shafer, Pradip Bajgain et al. · Journal for ImmunoTherapy of Cancer · 2021 · 73 citations · Full text

Medicine, Immunology, Oncology +17

Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia

Pınar Ataca Atilla, Mary K. McKenna, Haruko Tashiro et al. · Journal for ImmunoTherapy of Cancer · 2020 · 66 citations · Full text

Medicine, Immunology, Oncology +17